Effect of simeprevir (SMV) and/or sofosbuvir (SOF) containing regimens in patients with chronic hepatitis C

Trial Profile

Effect of simeprevir (SMV) and/or sofosbuvir (SOF) containing regimens in patients with chronic hepatitis C

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Jun 2015

At a glance

  • Drugs Simeprevir (Primary) ; Sofosbuvir (Primary) ; Peginterferon alfa; Ribavirin
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Jun 2015 New trial record
    • 20 May 2015 Results presented at the 20th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top